Browse studies, page 393

Page 393 of 1,298, newest first. Search them all at once, ranked by relevance, in Evidence Hub.

• Association between proton pump inhibitors and dementia risk: a Mendelian randomization study Scientific reports, 2024
• Impact of Proton Pump Inhibitor Use on Progression-Free and Overall Survival in Cancer Patients Undergoing Immune Checkpoint Inhibitor Therapy: A Systematic Review and Meta-Analysis of Recent Studies Cancers, 2025
• Assessment of Burden of Partial Response to Standard Doses of Proton Pump Inhibitors in Patients with Clinically Diagnosed Gastroesophageal Reflux Disease: A Real-World Evidence Study in India Drugs - real world outcomes, 2025
• Sexual Dysfunctions Associated with Proton Pump Inhibitors: Insights from VigiBase, the World Health Organization Pharmacovigilance Database Drug safety, 2026
• Integrated Analysis of Vonoprazan Safety for Symptomatic Gastro-Oesophageal Reflux Disease or Erosive Oesophagitis Alimentary pharmacology & therapeutics, 2025
• Association of probiotic use with nivolumab efficacy in gastric cancer patients on gastric acid suppressants iScience, 2026
• Advancing Evidence-Based Medicine for Population, Intervention, Comparison, and Outcome Element Recognition and Extraction in Medical Literature: Large Language Model Approach Journal of medical Internet research, 2026
• Comparative Efficacy of Triple Versus Quadruple Therapy for the Eradication of Helicobacter pylori Infection in Asian Adults-A Systematic Review and Meta-Analysis JGH open : an open access journal of gastroenterology and hepatology, 2025
• In vitro susceptibility testing of Trichomonas gallinae strains to proton pump inhibitors and nitroimidazoles Scientific reports, 2025
• Influence of patient characteristics on Helicobacter pylori eradication with Vonoprazan: A subgroup analysis of the pHalcon-HP trial JGH open : an open access journal of gastroenterology and hepatology, 2024
• Stress Ulcer Prophylaxis in Critical Care: Evidence, Risk Stratification, and Clinical Implications Cureus, 2026
• Proton pump inhibitors reduce survival outcomes in patients treated with capecitabine: meta-analysis Ecancermedicalscience, 2025
• Effect of proton pump inhibitors on occlusion of lumen-apposing metal stents and rate of endoscopic necrosectomies: a Europe-wide multicenter cohort study Endoscopy, 2025
• Characteristics affecting health-related quality of life (HRQOL) in Japanese patients with reflux oesophagitis and the effect of lansoprazole on HRQOL. Journal of medical economics, 2009
• Occurrence of community-acquired respiratory tract infection in patients receiving esomeprazole: retrospective analysis of adverse events in 31 clinical trials Drug safety, 2008
• Impact of oesophagitis classification in evaluating healing of erosive oesophagitis after therapy with proton pump inhibitors: a pooled analysis European journal of gastroenterology & hepatology, 2010
• The impact of lifestyle modification on the health-related quality of life of patients with reflux esophagitis receiving treatment with a proton pump inhibitor The American journal of gastroenterology, 2009
• Lifestyle factors and efficacy of lifestyle interventions in gastroesophageal reflux disease patients with functional dyspepsia: primary care perspectives from the LEGEND study Internal medicine (Tokyo, Japan), 2015
• Clinical outcomes of eradication of Helicobacter pylori in nonulcer dyspepsia in a population with a high prevalence of infection: results of a 12-month randomized, double blind, placebo-controlled study Digestive diseases and sciences, 2006
• Interaction between clopidogrel and proton-pump inhibitors Expert review of clinical pharmacology, 2010
• Heartburn severity does not predict disease severity in patients with erosive esophagitis MedGenMed : Medscape general medicine, 2006
• Lansoprazole and Helicobacter pylori infection Clinical Therapeutics, 1993
• Pre-anaesthetic oral lansoprazole for the prophylaxis of Mendelson′s syndrome and impact of duodenogastric reflux on pH and volume of gastric contents Saudi Journal of Anaesthesia, 2008
• Efficacy of low-dose lansoprazole in the treatment of non-erosive gastrooesophageal reflux disease. Influence of infection by Helicobacter pylori Revista Espanola de Enfermedades Digestivas, 2006
• Ultrasonographic evaluation of lansoprazole-induced improvement of submucosal injury in patients with gastroesophageal reflux American Journal of Gastroenterology, 2000
• Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy American Journal of Gastroenterology, 1997
• Miconazole gel increases the cure rate of Helicobacter pylori infection when added to lansoprazole and amoxicillin in a randomized trial Helicobacter, 1998
• Celecoxib plus aspirin versus naproxen and lansoprazole plus aspirin: a randomized, double-blind, endoscopic trial Clinical Gastroenterology and Hepatology, 2007
• A randomised clinical trial of 10-day concomitant therapy and standard triple therapy for Helicobacter pylori eradication Digestive and Liver Disease, 2014
• Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6- or 24-month dual-antiplatelet therapy duration: Insights from the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trial American Heart Journal, 2016
• A Clinical Trial of Proton Pump Inhibitors to Treat Children with Chronic Otitis Media with Effusion The journal of international advanced otology, 2018
• Clinical trial: intragastric acid control in patients who have Barrett’s oesophagus—comparison of once‐ and twice‐daily regimens of esomeprazole and lansoprazole Alimentary Pharmacology and Therapeutics, 2009
• Helicobacter pylori eradication using tetracycline and furazolidone versus amoxicillin and azithromycin in lansoprazole based triple therapy: an open randomized clinical trial Arquivos de Gastroenterologia, 2005
• Continuous versus on-demand proton pump inhibitor treatment for laryngopharyngeal reflux: a randomized clinical trial International Journal of Applied Pharmaceutics, 2019
• A Randomized Clinical Trial of Proton Pump Inhibitors Combined with Traditional Chinese Medicine in the Treatment of Laryngopharyngeal Reflux Disease Acupuncture & Electro-Therapeutics Research, 2022
• The proton pump inhibitor, lansoprazole, prevents the development of non-traumatic osteonecrosis of the femoral head: an experimental and prospective clinical trial European Journal of Orthopaedic Surgery & Traumatology, 2020
• The effect of adding duloxetine to lansoprazole on symptom and quality of life improvement in patients with gastroesophageal reflux diseases: A randomized double-blind clinical trial Journal of Research in Medical Sciences, 2021
• The Safety and Efficacy of Lansoprazole plus Metoclopramide among Neonates with Gastroesophageal Reflux Disease Resistant to Conservative Therapy and Monotherapy: A Clinical Trial International Journal of Pediatrics, 2021
• Profiling biopharmaceutical deciding properties of absorption of lansoprazole enteric-coated tablets using gastrointestinal simulation technology International journal of pharmaceutics, 2013
• Effect of fluoxetine on the pharmacokinetics of lansoprazole: a two-treatment period study in healthy male subjects Clinical drug investigation, 2011
• Clinical Characteristics of Patients with Gastroesophageal Reflux Disease Refractory to Proton Pump Inhibitors and the Effects of Switching to 20 mg Esomeprazole on Reflux Symptoms and Quality of Life Medical science monitor : international medical journal of experimental and clinical research, 2015
• The effect of Helicobacter pylori eradication on insulin resistance and HbA1c level in people with normal glucose levels: a prospective study Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia, 2015
• Comparison of the effect of a single dose of omeprazole or lansoprazole on intragastric pH in Japanese participants: a two-way crossover study Journal of the Chinese Medical Association : JCMA, 2013
• Comparison of acid inhibition with standard dosages of proton pump inhibitors in relation to CYP2C19 genotype in Japanese European journal of clinical pharmacology, 2014
• Changes in the quality of life of patients with laryngopharyngeal reflux after treatment Journal of voice : official journal of the Voice Foundation, 2014
• Pharmacokinetics of lansoprazole and its main metabolites after single and multiple intravenous doses in healthy Chinese subjects European journal of drug metabolism and pharmacokinetics, 2013
• Impact of gastroesophageal reflux on longitudinal lung function and quantitative computed tomography in the COPDGene cohort Respiratory research, 2020
• The Association between ABCB1 C1236T/C3435T SNPs and H. pylori Infection among Jordanians Genes, 2020
• The efficacy of two-week quadruple first-line therapy with bismuth, lansoprazole, amoxicillin, clarithromycin on Helicobacter pylori eradication: a prospective study Helicobacter, 2013
• The INGENIOUS trial: Impact of pharmacogenetic testing on adverse events in a pragmatic clinical trial The pharmacogenomics journal, 2023
• Efficacy of quadruple regimen with polaprezinc for gastric Helicobacter pylori infection eradication: protocol for a single-centre, single-blind, non-inferiority, randomised clinical trial BMJ open, 2020
• Effect and safety of anaprazole in the treatment of duodenal ulcers: a randomized, rabeprazole-controlled, phase III non-inferiority study Chinese medical journal, 2022
• DICE: Dual mTorc Inhibition in advanCed/recurrent Epithelial ovarian cancer resistant to standard treatment-a study protocol for a randomised trial investigating a novel therapy called TAK228 Trials, 2022
• Phenotyping of CYP 4501A2 Activity by Total Overnight Salivary Caffeine Assessment (TOSCA) in Patients on Warfarin Treatment: A Cross-Sectional Study Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2018
• Randomised clinical trial: efficacy and safety of vonoprazan vs. lansoprazole in patients with gastric or duodenal ulcers - results from two phase 3, non-inferiority randomised controlled trials Alimentary pharmacology & therapeutics, 2017
• Population pharmacokinetics of crenolanib in children and young adults with brain tumors Cancer chemotherapy and pharmacology, 2022
• Reduced Respiratory Syncytial Virus Load, Symptoms, and Infections: A Human Challenge Trial of MVA-BN-RSV Vaccine The Journal of infectious diseases, 2023
• Effectiveness and Safety of Enteric-Coated vs Uncoated Aspirin in Patients With Cardiovascular Disease: A Secondary Analysis of the ADAPTABLE Randomized Clinical Trial JAMA cardiology, 2023
• Possible effect of blonanserin on gambling disorder: A clinical study protocol and a case report World journal of clinical cases, 2021
• Efficacy of vonoprazan in prevention of bleeding from endoscopic submucosal dissection-induced gastric ulcers: a prospective randomized phase II study Journal of gastroenterology, 2019
• Comparison of oral and intravenous lansoprazole for the prevention of bleeding from artificial ulcers after endoscopic submucosal dissection for gastric tumors: a prospective randomized phase II study (KDOG 0802) Surgical endoscopy, 2018
• Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA prevention (KD-CAAP) trial protocol Trials, 2023
• A double-blind randomised placebo-controlled trial of percutaneous coronary intervention for the relief of stable angina without antianginal medications: design and rationale of the ORBITA-2 trial EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2022
• Outcomes of endoscopic submucosal dissection for gastroesophageal reflux disease (ESD-G) for medication-refractory gastroesophageal reflux disease: 35 cases underwent ESD-G including 15 cases followed more than 5 years BMC gastroenterology, 2021
• Investigation of the bioequivalence of two lansoprazole formulations in healthy Chinese volunteers after a single oral administration Artificial cells, nanomedicine, and biotechnology, 2017
• The impact of proton pump inhibitors on the pharmacokinetics of voriconazole in vitro and in vivo Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018
• PRIMMO study protocol: a phase II study combining PD-1 blockade, radiation and immunomodulation to tackle cervical and uterine cancer BMC cancer, 2019
• Randomised controlled trial combining vitamin E-functionalised chocolate with physical exercise to reduce the risk of protein-energy malnutrition in predementia aged people: study protocol for Choko-Age BMJ open, 2023
• Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study Cancer immunology, immunotherapy : CII, 2023
• A phase I, open-label, single-dose study to evaluate the effect of hepatic impairment on the pharmacokinetics and safety of futibatinib Clinical and translational science, 2023
• Assessment of the Effects of Abrocitinib on the Pharmacokinetics of Probe Substrates of Cytochrome P450 1A2, 2B6 and 2C19 Enzymes and Hormonal Oral Contraceptives in Healthy Individuals European journal of drug metabolism and pharmacokinetics, 2024
• Varoglutamstat: Inhibiting Glutaminyl Cyclase as a Novel Target of Therapy in Early Alzheimer's Disease Journal of Alzheimer's disease : JAD, 2024
• EMBIO trial study protocol: left gastric artery embolisation for weight loss in patients living with obesity with a BMI 35-50 kg/m2 BMJ open, 2023
• A phase I drug-drug interaction study to assess the effect of futibatinib on P-gp and BCRP substrates and of P-gp inhibition on the pharmacokinetics of futibatinib Clinical and translational science, 2024
• Use of proton pump inhibitors to treat persistent throat symptoms: multicentre, double blind, randomised, placebo controlled trial BMJ (Clinical research ed.), 2021
• Phase IV adaptive randomised clinical trials evaluating efficacy and cost-efficacy of pre-emptive pharmacogenetic genotyping strategies in the Spanish National Health System: iPHARMGx Master Protocol and PREVESTATGx nested clinical trial BMJ open, 2024
• Effectiveness and cost-effectiveness of a collaborative deprescribing intervention of proton-pump-inhibitors on community-dwelling older adults: Protocol for the C-SENIoR, a pragmatic non-randomized controlled trial PloS one, 2024
• A Modified 14-Day Dual Therapy with Vonoprazan and Amoxicillin Amplified the Advantages Over Conventional Therapies for Eradication of Helicobacter pylori: A Non-Inferiority Clinical Trial Infection and drug resistance, 2023
• LOTUS: Protocol for a double-blind placebo controlled randomized trial of hemp-derived cannabidiol for the treatment of cannabis use disorder PloS one, 2024
• The PROPHECI trial: a phase II, double-blind, placebo-controlled, randomized clinical trial for the treatment of pseudoxanthoma elasticum with oral pyrophosphate Trials, 2025
• Vonoprazan is noninferior to proton pump inhibitors in bismuth-containing quadruple therapy for the treatment of Helicobacter pylori infection: A propensity score matching analysis Journal of digestive diseases, 2023
• Dual-vector rAAVrh8 gene therapy for GM2 gangliosidosis: a phase 1/2 trial Nature medicine, 2025
• Effectiveness of a Collaborative Deprescribing Intervention of Proton Pump Inhibitors on Community-Dwelling Older Adults: The C-SENIoR Pragmatic Non-randomised Controlled Trial Drugs & aging, 2025
• Trial of alginates in throat symptoms: protocol for a pragmatic, multicentre, placebo controlled, double blind, parallel, randomised controlled trial of liquid alginate (Gaviscon Advance) for the treatment of persistent throat symptoms BMJ open, 2025
• High Prescription Rate of Medications With Rifampin Drug-drug Interactions in Patients With Diabetic Foot Osteomyelitis: Should Rifabutin Be Included in Clinical Trials for Adjunctive Therapy? Open forum infectious diseases, 2024
• Circulating immune cell profiling in advanced cervical and endometrial cancer patients treated with PD-1 blockade, radiotherapy, and immune modulation in the PRIMMO trial Frontiers in immunology, 2026
• Primary carE PPi dEprescRibing (PEPPER) trial: a protocol for determining the optimal strategy for stopping chronic proton pump inhibitor therapy in primary care patients BMJ open, 2026
• The effectiveness and risks of Treating people with Idiopathic Pulmonary fibrosis with the Addition of Lansoprazole (TIPAL): study protocol for a randomised placebo-controlled multicentre clinical trial BMJ open, 2025
• Pharmacokinetic Profiles of Lansoprazole in Patients With Morbid Obesity Post-Roux-en-Y Gastric Bypass Surgery Clinical and translational science, 2025
• Quadruple therapy for symptomatic spontaneous duodenal ulcer disease Postgraduate medical journal, 2001
• Lack of pharmacokinetic interaction between lansoprazole and intravenously administered phenytoin Journal of clinical pharmacology, 1999
• Lanzoptol efficiency for heartburn alleviation in patients with NERD Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, 2009
• Efficacy of lansoprazole against peptic ulcers induced by non-steroidal anti-inflammatory drugs: endoscopic evaluation of ulcer healing The Journal of international medical research, 1997
• Different effects of short-term omeprazole, lansoprazole or pantoprazole on the accuracy of the (13)C-urea breath test Alimentary pharmacology & therapeutics, 2002
• In treatment of active duodenal ulcer and Helicobacter pylori eradication Hepato-gastroenterology, 2003
• Lansoprazole treatment of Helicobacter pylori-positive peptic ulcers Journal of clinical gastroenterology, 1995
• Impact of clarithromycin resistance and CYP2C19 genetic polymorphism on treatment efficacy of Helicobacter pylori infection with lansoprazole- or rabeprazole-based triple therapy in Japan European journal of gastroenterology & hepatology, 2003
• Effects of uptake and efflux transporter inhibition on erythromycin breath test results Clinical pharmacology and therapeutics, 2007
• Rapid effect of lansoprazole on intragastric pH: a crossover comparison with omeprazole Scandinavian journal of gastroenterology, 1999
• Therapeutic effects of lansoprazole on peptic ulcers in elderly patients Journal of clinical gastroenterology, 1995